Literature DB >> 10419730

Presence of an eosinophilic infiltrate in cervical squamous carcinoma results from a type 2 immune response.

W J van Driel1, P Kievit-Tyson, L C van den Broek, A H Zwinderman, B J Trimbos, G J Fleuren.   

Abstract

OBJECTIVES: The presence of an eosinophilic infiltrate in patients with cervical squamous carcinoma has been shown to correlate with a worse overall survival, suggesting a less effective immune response in these cases. Since type 2 cytokines such as IL-4 and IL-5 are known to attract eosinophilic granulocytes, an immunohistochemical study was performed to gain further insight as to whether a type 1 or type 2 immune response is involved in eliciting an eosinophilic infiltrate.
MATERIAL AND METHODS: Frozen tissue sections of 9 normal cervical tissues, 23 premalignant cervical lesions, and 23 cervical squamous carcinomas were stained by immunohistochemistry with monoclonal antibodies directed against IFN-gamma and IL-4 as representatives of a type 1 or a type 2 response, respectively.
RESULTS: Normal tissues and premalignant lesions of the cervix did not contain eosinophilic granulocytes and showed very few IL-4- and IFN-gamma-positive cells. In cervical carcinoma the presence of IL-4 on tumor infiltrating cells correlated with the presence of eosinophilic granulocytes in the tumor (P value <0.01) and stroma (P value <0.05). IFN-gamma-positive cells did not show any such correlation. In addition, colocalization was observed of CD3- and IL-4-positive T lymphocytes indicating that IL-4 production is mediated by T lymphocytes.
CONCLUSION: The relative increase of IL-4-positive cells in the presence of an eosinophilic infiltrate might thus reflect an imbalance between a type 1 and type 2 response, in favor of the latter. Since a type 1 response stimulates an adequate cellular response which is negatively regulated by type 2 cytokines, these findings might explain the worse clinical outcome seen in cervical cancer patients with an eosinophilic tumor infiltrate. These results may have implications when developing immunotherapeutical strategies for cervical cancer. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10419730     DOI: 10.1006/gyno.1999.5431

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  4 in total

Review 1.  Therapeutic strategies for harnessing human eosinophils in allergic inflammation, hypereosinophilic disorders, and cancer.

Authors:  Zhaleh J Amini-Vaughan; Margarita Martinez-Moczygemba; David P Huston
Journal:  Curr Allergy Asthma Rep       Date:  2012-10       Impact factor: 4.806

2.  Expression of interleukin-5 and tumor necrosis factor alpha in cervical carcinoma.

Authors:  Dae Woo Lee; Young Tae Kim; Sang Wun Kim; SungHoon Kim; Jae Hoon Kim; Myung Hwa Kang; Jeong Hye Hwang; Jong baeck Lim
Journal:  Clin Vaccine Immunol       Date:  2009-04-15

3.  Significance of neo-angiogenesis and immuno-surveillance cells in squamous cell carcinoma of the tongue.

Authors:  Juma O Alkhabuli
Journal:  Libyan J Med       Date:  2007-03-01       Impact factor: 1.657

4.  Tumor eosinophil infiltration and improved survival of colorectal cancer patients: Iowa Women's Health Study.

Authors:  Anna E Prizment; Robert A Vierkant; Thomas C Smyrk; Lori S Tillmans; James J Lee; P Sriramarao; Heather H Nelson; Charles F Lynch; Stephen N Thibodeau; Timothy R Church; James R Cerhan; Kristin E Anderson; Paul J Limburg
Journal:  Mod Pathol       Date:  2016-02-26       Impact factor: 7.842

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.